{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:01:49Z","timestamp":1780538509719,"version":"3.54.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["493624047"],"award-info":[{"award-number":["493624047"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI) is a serious and common complication among patients undergoing major surgery. The underlying pathophysiologic mechanism includes ischemia-reperfusion injury, complement activation, oxidative stress, and heme toxicity. Among potential preventive measures, recombinant alpha-1 microglobulin (A1M) emerged as a promising therapeutic candidate to mitigate kidney injury in high-risk clinical settings. Preclinical studies have shown its protective effect in different in vitro models such as cellular damage induced by radiation, proteases, and oxidative stress. In animal models, pretreatment with A1M significantly attenuated glomerular permeability changes induced by free fetal hemoglobin, reduced markers of oxidative injury in radiation-induced kidney damage, and conferred protection in ischemia-reperfusion injury by stabilizing mitochondrial function. These promising results led to the use of A1M in human patients. In Phase 1 clinical trials, RMC-035 demonstrated a safety profile with predictable, dose-linear pharmacokinetics. Moreover, in a Phase 1 study involving cardiac surgery patients, RMC-035 showed early signals of renal protection as indicated by reductions of renal tubular stress and injury biomarkers. Although a Phase 2 trial in cardiac surgery patients did not meet its primary endpoint of reducing the rate of AKI within 72 hours after surgery, a significant decline in major adverse kidney events at 90 days was observed that was mainly driven by a reduced rate of persistent renal dysfunction. An ongoing Phase 2b study aims to refine dosing strategies and better delineate its long-term renoprotective efficacy. Collectively, these studies seek to answer whether RMC-035 may improve kidney outcomes in settings characterized by oxidative and ischemia-reperfusion injury.<\/jats:p>","DOI":"10.1093\/ndt\/gfaf194","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:59:34Z","timestamp":1758887974000},"page":"649-656","source":"Crossref","is-referenced-by-count":2,"title":["Recombinant alpha-1 microglobulin to improve outcomes in survivors of AKI"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-6297","authenticated-orcid":false,"given":"Matteo","family":"Marcello","sequence":"first","affiliation":[{"name":"University of Muenster Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, , Muenster ,","place":["Germany"]},{"name":"Dialysis and Transplantation, San Bortolo Hospital Department of Nephrology, , Vicenza ,","place":["Italy"]},{"name":"International Renal Research Institute Vicenza, IRRIV , Vicenza ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig Maximilian","family":"Sch\u00f6ne","sequence":"additional","affiliation":[{"name":"University of Muenster Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, , Muenster ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Booke","sequence":"additional","affiliation":[{"name":"University of Muenster Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, , Muenster ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Hognon-B\u0105k","sequence":"additional","affiliation":[{"name":"St. Raphael Hospital Department of Anesthesiology and Intensive Care, , Cracow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[{"name":"University of Muenster Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, , Muenster ,","place":["Germany"]},{"name":"Critical Care and Pain Medicine, The University of Texas Health Science Center at Houston Department of Anesthesiology, , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"2026033111014174700_bib1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrneph.2011.13","article-title":"Acute kidney injury: what\u2019s the prognosis?","volume":"7","author":"Murugan","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2026033111014174700_bib2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026033111014174700_bib3","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Writing Group for the CKD Prognosis Consortium","year":"2023","journal-title":"JAMA"},{"key":"2026033111014174700_bib4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1159\/000489241","article-title":"Current mechanistic concepts in ischemia and reperfusion injury","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2026033111014174700_bib5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrneph.2017.119","article-title":"Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment","volume":"13","author":"Wang","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026033111014174700_bib6","doi-asserted-by":"publisher","first-page":"e8046","DOI":"10.7717\/peerj.8046","article-title":"Oxidative stress as a potential target in acute kidney injury","volume":"7","author":"Tomsa","year":"2019","journal-title":"PeerJ"},{"key":"2026033111014174700_bib7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00134-023-07169-7","article-title":"Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study","volume":"49","author":"Zarbock","year":"2023","journal-title":"Intensive Care Med"},{"key":"2026033111014174700_bib8","doi-asserted-by":"publisher","first-page":"6193694","DOI":"10.1155\/2017\/6193694","article-title":"Oxidative stress and acute kidney injury in critical illness: pathophysiologic mechanisms-biomarkers-interventions, and future perspectives","volume":"2017","author":"Pavlakou","year":"2017","journal-title":"Oxid Med Cell Long"},{"key":"2026033111014174700_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2014.06.025","article-title":"A1M, an extravascular tissue cleaning and housekeeping protein","volume":"74","author":"\u00c5kerstr\u00f6m","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"2026033111014174700_bib10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2004.12.013","article-title":"Redox properties of the lipocalin alpha1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron","volume":"38","author":"Allhorn","year":"2005","journal-title":"Free Radical Biol Med"},{"key":"2026033111014174700_bib11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/antiox10081271","article-title":"Kidney protection with the radical scavenger \u03b11-microglobulin (A1M) during peptide receptor radionuclide and radioligand therapy","volume":"10","author":"Kristiansson","year":"2021","journal-title":"Antioxidants"},{"key":"2026033111014174700_bib12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exer.2018.04.012","article-title":"Acute tissue reactions, inner segment pathology, and effects of the antioxidant \u03b11-microglobulin in an in vitro model of retinal detachment","volume":"173","author":"Ghosh","year":"2018","journal-title":"Exp Eye Res"},{"key":"2026033111014174700_bib13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/10715760802337265","article-title":"The lipocalin alpha1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species","volume":"42","author":"Olsson","year":"2008","journal-title":"Free Radical Res"},{"key":"2026033111014174700_bib14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13052-024-01709-7","article-title":"Changes in urinary renal injury markers in children with Mycoplasma pneumoniae pneumonia and a prediction model for related early renal injury","volume":"50","author":"Zhang","year":"2024","journal-title":"Ital J Pediatr"},{"key":"2026033111014174700_bib15","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1182\/blood.V99.6.1894","article-title":"Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties","volume":"99","author":"Allhorn","year":"2002","journal-title":"Blood"},{"key":"2026033111014174700_bib16","doi-asserted-by":"publisher","first-page":"e27505","DOI":"10.1371\/journal.pone.0027505","article-title":"Up-regulation of A1M\/\u03b11-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage","volume":"6","author":"Olsson","year":"2011","journal-title":"PLoS ONE"},{"key":"2026033111014174700_bib17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1089\/ars.2018.7517","article-title":"Protection of kidney function with human antioxidation protein \u03b11-microglobulin in a mouse 177Lu-DOTATATE radiation therapy model","volume":"30","author":"Kristiansson","year":"2019","journal-title":"Antioxid Redox Signaling"},{"key":"2026033111014174700_bib18","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00259-016-3382-9","article-title":"Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate","volume":"43","author":"Bergsma","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026033111014174700_bib19","doi-asserted-by":"publisher","first-page":"F442","DOI":"10.1152\/ajprenal.00502.2013","article-title":"Extracellular fetal hemoglobin induces increases in glomerular permeability: inhibition with \u03b11-microglobulin and tempol","volume":"306","author":"Sverrisson","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026033111014174700_bib20","doi-asserted-by":"publisher","first-page":"e86353","DOI":"10.1371\/journal.pone.0086353","article-title":"A1M\/\u03b11-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia","volume":"9","author":"Wester-Rosenl\u00f6f","year":"2014","journal-title":"PLoS ONE"},{"key":"2026033111014174700_bib21","doi-asserted-by":"publisher","first-page":"F103","DOI":"10.1152\/ajprenal.00067.2024","article-title":"Therapeutic \u03b1-1-microglobulin ameliorates kidney ischemia-reperfusion injury","volume":"327","author":"Burmakin","year":"2024","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026033111014174700_bib22","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1016\/S0021-9258(17)40934-3","article-title":"Human alpha1-microglobulin. Purification procedure, chemical and physiochemical properties","volume":"252","author":"Ekstr\u00f6m","year":"1977","journal-title":"J Biol Chem"},{"key":"2026033111014174700_bib23","article-title":"RMC-035\u2013Guard Therapeutics"},{"key":"2026033111014174700_bib24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ekir.2023.02.1071","article-title":"Recombinant alpha-1-microglobulin (RMC-035) to prevent acute kidney injury in cardiac surgery patients: phase 1b evaluation of safety and pharmacokinetics","volume":"8","author":"Weiss","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026033111014174700_bib25","doi-asserted-by":"publisher","first-page":"e1727","DOI":"10.1097\/TXD.0000000000001727","article-title":"Assessing pharmacokinetics and safety of therapeutic alpha-1-microglobulin in first-in-human kidney transplantation: a noncomparative open-label multiple-dose Phase 1b study","volume":"10","author":"Nordstr\u00f6m","year":"2024","journal-title":"Transplant Direct"},{"key":"2026033111014174700_bib26","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","journal-title":"Am J Transplant"},{"key":"2026033111014174700_bib27","doi-asserted-by":"publisher","first-page":"102830","DOI":"10.1016\/j.eclinm.2024.102830","article-title":"Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial","volume":"76","author":"Zarbock","year":"2024","journal-title":"EClinMed"},{"key":"2026033111014174700_bib28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","article-title":"Drug-induced acute kidney injury","volume":"17","author":"Perazella","year":"2022","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf194\/64418158\/gfaf194.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/4\/649\/64418158\/gfaf194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/4\/649\/64418158\/gfaf194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:01:47Z","timestamp":1774969307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/4\/649\/8266817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9,27]]},"published-print":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf194","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,9,27]]}}}